Palisade Bio Inc (PALI) Stock Price

1.41 ▼ -0.13 (-8.44%)
Open: 1.55 Vol: 3.89M Day's range: 1.40 - 1.56 Oct 16, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PALI Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.45▼ 1.44▼ 1.45▼ 1.50▼ 1.49▼
MA10 1.45▼ 1.46▼ 1.48▼ 1.49▼ 1.78▼
MA20 1.45▼ 1.48▼ 1.48▼ 1.50▼ 1.85▼
MA50 1.46▼ 1.48▼ 1.50▼ 1.82▼ 1.89▼
MA100 1.48▼ 1.50▼ 1.47▼ 1.88▼ 1.50▼
MA200 1.48▼ 1.47▼ 1.64▼ 1.89▼ 8.06▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ -0.008▼ -0.009▼ 0.017▲ -0.077▼
RSI 28.532▼ 29.784▼ 34.007▼ 38.750▼ 38.687▼
STOCH 75.000     10.227▼ 14.848▼ 54.606     17.243▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -70.968     -90.164▼
CCI -166.667▼ -164.679▼ -150.790▼ -27.824     -113.125▼
Latest Filters Detected On PALI
MA $PALI Price Crossed Below MA(13) Set Alert
MA $PALI Price Crossed Below MA(7) Set Alert
CDL $PALI Engulfing Candlestick Pattern Detected Set Alert
Palisade Bio Inc News
Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s ...
Monday, October 12, 2026 01:05 AM
Five presentations connect targeted intestinal exposure and sustained systemic drug exposure with PDE4 target engagement and early clinical ...
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
Monday, September 28, 2026 05:50 AM
Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s disease Three moderated posters to showcase gut-targeted exposure, favorable ...
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
Tuesday, September 22, 2026 01:35 AM
ASCENTRA-CD expected to enroll approximately 60 patients with moderate to severe Crohn’s diseaseFirst patient dosing targeted for Q1 2027; ...
PALI historical stock data
date open high low close volume
16/10/26 1.55 1.56 1.40 1.41 3,887,801
15/10/26 1.50 1.56 1.48 1.54 1,817,600
14/10/26 1.45 1.51 1.38 1.48 4,162,500
13/10/26 1.56 1.5789 1.46 1.465 1,580,270
12/10/26 1.53 1.63 1.51 1.59 1,571,700
09/10/26 1.49 1.57 1.47 1.54 1,841,007
08/10/26 1.47 1.48 1.38 1.45 1,984,403
07/10/26 1.46 1.48 1.44 1.48 825,232
06/10/26 1.51 1.55 1.47 1.49 1,972,700
05/10/26 1.44 1.48 1.41 1.46 1,590,487
Quote Details
52wk Low:1.32
52wk High:2.855
Vol:3.89M
Avg Vol(3m):45.9M
1Y Chng:-29.50%
1M Chng:-32.54%
Add to Watch List
More Information
Index US Composite
Market Cap. 268.38M